These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 11816697)
1. A prospective evaluation of the interleukin-1 receptor antagonist intron 2 gene polymorphism and the risk of myocardial infarction. Zee RY; Lunze K; Lindpaintner K; Ridker PM Thromb Haemost; 2001 Nov; 86(5):1141-3. PubMed ID: 11816697 [TBL] [Abstract][Full Text] [Related]
2. Allele 2 of the interleukin-1 receptor antagonist gene (IL1RN*2) is associated with a decreased risk of primary lung cancer. Hu Z; Shao M; Chen Y; Zhou J; Qian J; Xu L; Ma H; Wang X; Xu Y; Lu D; Shen H Cancer Lett; 2006 May; 236(2):269-75. PubMed ID: 16019127 [TBL] [Abstract][Full Text] [Related]
3. The interleukin-1 receptor antagonist gene and the inhibitor of kappa B-like protein gene polymorphisms are not associated with myocardial infarction in Slovene population with type 2 diabetes. Kariz S; Milutinović A; Bregar D; Terzić I; Terzić R; Lovrecić L; Herova M; Hruskovicova H; Peterlin B; Petrovic D; Zorc-Pleskovic R Coll Antropol; 2007 Jun; 31(2):503-7. PubMed ID: 17847930 [TBL] [Abstract][Full Text] [Related]
4. Interleukin 1 receptor antagonist gene polymorphism and risk of lung cancer: a possible interaction with polymorphisms in the interleukin 1 beta gene. Lind H; Zienolddiny S; Ryberg D; Skaug V; Phillips DH; Haugen A Lung Cancer; 2005 Dec; 50(3):285-90. PubMed ID: 16126303 [TBL] [Abstract][Full Text] [Related]
5. A prospective evaluation of the heat shock protein 70 gene polymorphisms and the risk of stroke. Zee RY; Bates D; Ridker PM Thromb Haemost; 2002 Apr; 87(4):622-5. PubMed ID: 12008944 [TBL] [Abstract][Full Text] [Related]
6. Polymorphism in the interleukin-1 receptor antagonist gene is associated with alcoholism in Spanish men. Pastor IJ; Laso FJ; Avila JJ; Rodríguez RE; González-Sarmiento R Alcohol Clin Exp Res; 2000 Oct; 24(10):1479-82. PubMed ID: 11045853 [TBL] [Abstract][Full Text] [Related]
7. Alu-repeat polymorphism in the gene coding for tissue-type plasminogen activator (t-PA) and risks of myocardial infarction among middle-aged men. Ridker PM; Baker MT; Hennekens CH; Stampfer MJ; Vaughan DE Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1687-90. PubMed ID: 9327764 [TBL] [Abstract][Full Text] [Related]
8. Lack of association between a common polymorphism near the INSIG2 gene and BMI, myocardial infarction, and cardiovascular risk factors. Wiedmann S; Neureuther K; Stark K; Reinhard W; Kallmünzer B; Baessler A; Fischer M; Linsel-Nitschke P; Erdmann J; Schunkert H; Hengstenberg C Obesity (Silver Spring); 2009 Jul; 17(7):1390-5. PubMed ID: 19197259 [TBL] [Abstract][Full Text] [Related]
9. Polymorphism of the interleukin-1 receptor antagonist gene: a factor in susceptibility to rheumatoid arthritis in a Spanish population. Carreira PE; Gonzalez-Crespo MR; Ciruelo E; Pablos JL; Santiago B; Gomez-Camara A; Gomez-Reino JJ Arthritis Rheum; 2005 Oct; 52(10):3015-9. PubMed ID: 16200608 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of interleukin-1 receptor antagonist gene polymorphism and cytomegalovirus seroprevalence in patients with coronary artery disease. Rothenbacher D; Brenner H; Mertens T; Hoffmann MM; Hoffmeister A; Koenig W BMC Cardiovasc Disord; 2005 May; 5(1):10. PubMed ID: 15943888 [TBL] [Abstract][Full Text] [Related]
11. Haplotypes of IL1B, IL1RN, IL1R1, and IL1R2 and the risk of venous thrombosis. van Minkelen R; de Visser MC; Houwing-Duistermaat JJ; Vos HL; Bertina RM; Rosendaal FR Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1486-91. PubMed ID: 17413037 [TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor-gamma2 P12A polymorphism and risk of coronary heart disease in US men and women. Pischon T; Pai JK; Manson JE; Hu FB; Rexrode KM; Hunter D; Rimm EB Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1654-8. PubMed ID: 15920035 [TBL] [Abstract][Full Text] [Related]
13. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease. Chourasia D; Achyut BR; Tripathi S; Mittal B; Mittal RD; Ghoshal UC Am J Gastroenterol; 2009 Nov; 104(11):2704-13. PubMed ID: 19603010 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 receptor antagonist VNTR-polymorphism in inflammatory bowel disease. Vijgen L; Van Gysel M; Rector A; Thoelen I; Esters N; Ceelen T; Vangoidsenhoven E; Vermeire S; Rutgeerts P; Van Ranst M Genes Immun; 2002 Nov; 3(7):400-6. PubMed ID: 12424621 [TBL] [Abstract][Full Text] [Related]
16. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India. Mittal RD; Bid HK; Ghoshal UC Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659 [TBL] [Abstract][Full Text] [Related]
17. Analysis of the association of IL1B (C+3954T) and IL1RN (intron 2) polymorphisms with dental implant loss in a Brazilian population. Montes CC; Alvim-Pereira F; de Castilhos BB; Sakurai ML; Olandoski M; Trevilatto PC Clin Oral Implants Res; 2009 Feb; 20(2):208-17. PubMed ID: 19191798 [TBL] [Abstract][Full Text] [Related]
18. A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam Study. Kardys I; Klaver CC; Despriet DD; Bergen AA; Uitterlinden AG; Hofman A; Oostra BA; Van Duijn CM; de Jong PT; Witteman JC J Am Coll Cardiol; 2006 Apr; 47(8):1568-75. PubMed ID: 16630992 [TBL] [Abstract][Full Text] [Related]
19. The common Y402H variant in complement factor H gene is not associated with susceptibility to myocardial infarction and its related risk factors. Stark K; Neureuther K; Sedlacek K; Hengstenberg W; Fischer M; Baessler A; Wiedmann S; Jeron A; Holmer S; Erdmann J; Schunkert H; Hengstenberg C Clin Sci (Lond); 2007 Aug; 113(4):213-8. PubMed ID: 17472578 [TBL] [Abstract][Full Text] [Related]
20. 5-Hydroxytryptamine 5-HT2A receptor and 5-hydroxytryptamine transporter polymorphisms in acute myocardial infarction. Coto E; Reguero JR; Alvarez V; Morales B; Batalla A; González P; Martín M; García-Castro M; Iglesias-Cubero G; Cortina A Clin Sci (Lond); 2003 Mar; 104(3):241-5. PubMed ID: 12605580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]